HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rózsa Hegedüs Selected Research

gonadotropin-releasing hormone-III

9/2019Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells.
1/2018Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids.
1/2016Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice.
12/2015[Studying the tumor growth inhibitory effect of modified GnRH-III-anthracycline bioconjugates in subcutaneous vs. orthotopic models in vivo].
5/2015Modification of daunorubicin-GnRH-III bioconjugates with oligoethylene glycol derivatives to improve solubility and bioavailability for targeted cancer chemotherapy.
10/2012Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rózsa Hegedüs Research Topics

Disease

7Neoplasms (Cancer)
09/2019 - 01/2011
2Colonic Neoplasms (Colon Cancer)
09/2019 - 12/2015
2Colorectal Neoplasms (Colorectal Cancer)
09/2019 - 01/2016
1COVID-19
01/2022
1Thrombosis (Thrombus)
01/2022
1Carcinoma (Carcinomatosis)
09/2019
1Melanoma (Melanoma, Malignant)
01/2018
1Breast Neoplasms (Breast Cancer)
05/2015

Drug/Important Bio-Agent (IBA)

6gonadotropin-releasing hormone-IIIIBA
09/2019 - 10/2012
5Daunorubicin (Cerubidine)FDA LinkGeneric
09/2019 - 01/2011
4LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
09/2019 - 10/2012
3Pharmaceutical PreparationsIBA
01/2022 - 12/2015
3Cytostatic AgentsIBA
12/2015 - 10/2012
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2019 - 01/2018
2Peptides (Polypeptides)IBA
01/2018 - 01/2016
2Peptide Hormones (Polypeptide Hormones)IBA
01/2018 - 12/2015
2Volatile Fatty AcidsIBA
01/2018 - 10/2012
2OximesIBA
01/2016 - 01/2011
1Proteins (Proteins, Gene)FDA Link
09/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2019
1Protein Isoforms (Isoforms)IBA
09/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2019
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2018
1Biological ProductsIBA
01/2018
1Butyric Acid (Butanoic Acid)IBA
01/2016
1Hormones (Hormone)IBA
01/2016
1Acetic Acid (Vinegar)FDA LinkGeneric
01/2016
1AnthracyclinesIBA
12/2015
14-fluorobenzaldehydeIBA
01/2011

Therapy/Procedure

4Drug Therapy (Chemotherapy)
01/2016 - 01/2011
2Therapeutics
01/2018 - 12/2015
1Ligation
01/2011